"Regardless of the research that’s to come, the authors say their findings already suggest that relying on tests or treatments that only take into account a person’s total levels of tau and amyloid in the brain may be sending researchers down the wrong path."

Don't miss a post

Follow this conversation to get notified about new posts. Find it later in the "Following" feed.